Former President Joe Biden has been diagnosed with an “aggressive form” of prostate cancer, according to a Sunday statement from his personal office. More: Former President Joe Biden diagnosed with 'aggressive' prostate cancer Source: fierce
read moreEisai has put direct-to-consumer advertising at the heart of efforts to expand demand for Leqembi. Seeking to grow prescriptions in the U.S., the Japanese drugmaker is targeting TV advertising at recently diagnosed Alzheimer’s disease patients. More: Eisai mounts targeted TV
read moreThe drugmaker Regeneron has won a bankruptcy auction for 23andMe and its DNA database gathered from some 15 million customers. More: Regeneron’s 6M bid wins 23andMe bankruptcy auction Source: fierce
read moreFor an upcoming FDA advisory committee meeting, the agency is questioning whether J&J, Pfizer and Roche have provided convincing clinical data for their cancer drugs in the right patient populations. More: Weighing approval bids from J&J, Pfizer and Roche, FDA
read moreIn a new public-private partnership, the Department of Health and Human Services and DARPA are linking up with several universities and companies in a bid to improve manufacturing for essential medicines in the U.S. using artificial intelligence, machine learning and
read moreThe FDA has lifted its 19-month clinical hold on vaginal yeast infection drug Brexafemme (ibrexafungerp), according to the treatment’s developer Scynexis. More: After 19 months, FDA lifts clinical hold on vaginal yeast infection drug Brexafemme Source: fierce
read more© 1994 - 2025 B.M. Pharmaceuticals